Dih Holding Us Inc's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Dih Holding Us Inc's ROI in the fourth quarter of 2025?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Dih Holding Us Inc 's return on investment (ROI) in its fourth quarter of 2025

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Mar 31 2025) IV. Quarter	(Dec 31 2024) III. Quarter	(Sep 30 2024) II. Quarter	(Jun 30 2024) I. Quarter	(Mar 31 2024) IV. Quarter
Y / Y Investment Change TTM	-	-	-	-93.1 %	-88.73 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-16	-16	-11	-10	-9
Return On Investment (TTM)	-	-	-	-	-
DHAI's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-55.25 %	-36.15 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-9	-13	-6	-9	-11

DHAI Company Profile >> Back to DHAI Roi Comparisons >> See Annual DHAI Return On Investment

Return On Investment DHAI's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Dih Holding Us Inc's IV. Quarter Investments	$ -16 Millions	DHAI's Balance sheet
Dih Holding Us Inc's IV. Quarter Income	$ -4 Millions	Quarterly DHAI's Income Statement
DHAI's Income by Division		See DHAI's Income by Division

DHAI Annual Return On Investment	(Mar 31 2025) 2025	(Mar 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022
Total Investments in Millions	-16	-9	47	200	0
Y / Y Investment Growth	-	-	-76.5 %	-	-
Net Income in Millions	-9	-8	1	7	0
Y / Y Net Income Growth	-	-	-90.31 %	-	-
Annual Return On Investment	-	-	1.36 %	3.3 %	-

Annual Roi Comment

Despite deterioration in net income, company improved ROI to in the fiscal year 2025, company improved ROI to 3.3 % compare to previous year.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DHAI's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DHAI's Competitors
Subscribers only: Roi for Dih Holding Us Inc's Suppliers
Subscribers only: Return On Investment for DHAI's Customers

Other Ratios
DHAI's Roa	DHAI's Inventory Turnover Ratio	DHAI's Growth Rates	DHAI's Dividend Statistics
	DHAI's Profitability Ratios	DHAI's Asset Turnover Ratio	DHAI's Dividend Growth
DHAI's Roe	DHAI's Valuation Ratios	DHAI's Financial Strength Ratios	DHAI's Dividend Payout Ratio

Companies with similar Return On Investment at Mar 31 2025, within Healthcare Sector	ROI
Cytomx Therapeutics Inc	139.64 %
Camp4 Therapeutics Corporation	136.24 %
Alumis inc	113.83 %
Stablecoin Development Corporation	110.75 %
Earth Science Tech Inc	100.58 %
Oak Woods Acquisition Corp	93.88 %
Avalo Therapeutics Inc	88.86 %
Tao Synergies Inc	78.95 %
Synlogic Inc	73.65 %
Novavax inc	71.31 %
Longduoduo Co Ltd	62.85 %
Medinotec Inc	60.77 %
Exelixis Inc	59.41 %
Gridai Technologies Corp	58.38 %
Adma Biologics Inc	53.77 %
Bluebird Bio Inc	52.44 %
Seres Therapeutics Inc	52.22 %
Pharmacyte Biotech Inc	48.77 %
Agios Pharmaceuticals Inc	48.46 %
Dariohealth Corp	44.97 %
Sbc Medical Group Holdings Incorporated	41.74 %
Champions Oncology Inc	41.16 %
Ptc Therapeutics inc	40.79 %
Rigel Pharmaceuticals Inc	39.96 %
Mettler toledo International Inc	39.75 %
Idexx Laboratories Inc	39.40 %
Edwards Lifesciences Corporation	38.53 %
Puma Biotechnology Inc	34.10 %
Hims and Hers Health Inc	34.04 %
Medpace Holdings Inc	33.49 %

Date modified: 2026-09-08T15:11:34+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.